Global Endometrial Ablation Devices Market Overview:
The Global Endometrial Ablation Devices Market generated $882 million in 2017, and is projected to reach $1,299 million by 2024, growing at a CAGR of 5.6% from 2018 to 2024. Endometrial ablation is a medical procedure used to remove or destroy the endometrial lining of the uterus for treatment of heavy menstrual bleeding. Factors such as increase in awareness regarding endometrial ablation, rise in prevalence of menorrhagia, and surge in demand for minimally invasive procedures are expected to boost the growth of the endometrial ablation devices market during the forecast period. Other factors such as technological advancement in endometrial ablation and benefits of the endometrial ablation over the surgical procedures facilitate the growth of the market. In addition, endometrial ablation offers some advantages over the other surgeries such as, shorter procedure time, efficiency, faster recovery, minimal invasion, and lower pain. These factors increase the demand for endometrial ablation derives around the world. However, stringent government regulations for the approval of endometrial ablation devices and risks associated with the endometrial ablation are expected to impede the market growth.
Endometrial Ablation Devices Market Segmentation
The global endometrial ablation devices market is segmented based on technology type, end user, and region. Based on technology, the market is divided into radiofrequency ablation, cryoablation, hydrothermal ablation, thermal balloon, hysteroscopic ablation, and others. Based on end user, market is classified into ambulatory surgery center, clinic, and hospital. Based on region, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Based on technology type, the endometrial ablation devices market is segmented into radiofrequency ablation, cryoablation, hydrothermal ablation, thermal balloon, hysteroscopic ablation, and others. At present, the radiofrequency ablation segment contributes for the highest market share among all technologies, and is anticipated to continue to remain dominant during the forecast period. There is an increase in the adoption of radiofrequency ablation technology in the market, due to its convenience, speed of treatment, and effectivity. On the other side, thermal balloon technology is anticipated to show fastest growth during the forecast period primarily due to its ease of use and convenience.
According to end user, the market is categorized as ambulatory surgery center, clinic, and hospital. At present, the clinic segment generates the highest revenue due to advancements in endometrial ablation techniques that do not require large space and hence can be used in the clinics. The ambulatory surgery center segment is projected to exhibit fastest market growth during the forecast period, due to the rise in number of centers, cost-effective services, and a convenient environment.
Snapshot of Asia-Pacific Endometrial Ablation Devices Market
Asia-Pacific presents lucrative opportunities for the players operating in the endometrial ablation devices market, owing to high population base, increase in demand for minimally invasive procedures, development in healthcare infrastructure, and rise in awareness about endometrial ablation techniques. Furthermore, increase in prevalence of menorrhagia and growth in demand for advanced technologies is anticipated to fuel the market growth. In addition, rise in number of ambulatory surgical centers and increase in availability of advanced endometrial ablation devices among the clinics support the growth of the endometrial ablation devices market in Asia-Pacific.
The key players profiled in this report include AEGEA Medical, Inc., Boston Scientific Corporation, CooperSurgical Inc., Hologic, Inc., Idoman Teoranta, Minerva Surgical, Inc., Olympus Corporation, Omnitech Systems, Inc., Smith & Nephew plc. (Medtronic plc.), and Veldana Medical SA.
- The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis from 2017 to 2024, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
- Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
- The profiles and growth strategies of key players are thoroughly analyzed to understand the competitive outlook of the global market.
Endometrial Ablation Devices Market Report Highlights
By End User
Key Market Players
AEGEA Medical, Inc., Omnitech Systems, Inc., Medtronic Plc. (Smith & Nephew Plc.), Olympus Corporation, Hologic, Inc., Veldana Medical SA, Boston Scientific Corporation, The Cooper Companies, Inc. (CooperSurgical, Inc.), Minerva Surgical, Inc., Idoman Teoranta
Endometrial ablation is a medical procedure adopted to remove or destroy the endometrial lining of the uterus for treatment of heavy menstrual bleeding after failure of medication therapy. The adoption of endometrial ablation devices is expected to increase due to rise in the prevalence of menstrual disorders and growth in demand for minimally invasive procedures.
Technological advancement in endometrial ablation devices and advantages of the endometrial ablation over other surgical procedures are expected to drive the growth of the market. Moreover, factors such as increase in health care expenditure and growth in demand for advanced medical devices are projected to supplement the market growth. Key advantages associated with the use of endometrial ablation such as speed of treatment, lower pain, and faster recovery are projected to support the market growth. However, stringent government regulations for the approval of endometrial ablation devices and risks associated with the use of endometrial ablation devices hamper the market growth.
North America is expected to dominate the global market during the forecast period due to higher awareness about endometrial ablation devices and increase in prevalence of menstrual disorders. In addition, Asia-Pacific and LAMEA are expected to offer lucrative opportunities to the key players during the forecast period.